If you're looking to uncover family history or learn more about your health, here's how to decide which DNA testing kit is ...

Texans curious about their ancestry likely paid for a DNA test through 23andMe. But with their future unclear, what will happen to customers' data?

23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.

All of 23andMe's independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company.

23andMe says on its website that any buyer must comply with laws around handling customer data. The company plans to continue selling kits and offering subscriptions.

Regeneron intends for 23andMe to continue its consumer genome services without interruption. The transaction, pending bankruptcy court and regulatory approvals, is expected to close in the third ...

23andMe, a genetic testing and biotech company, first announced in Oct. 2023 that the site had been the victim of a “credential stuffing attack,” during which hackers were able to use login ...

23andMe has faced an uncertain future for some time. Beyond battles to go private, the company struggled to find a profitable business model since going public in 2021.

23andMe, Anne Wojcicki, and New Mountain Capital declined to comment. Board experts say the bid will likely attract scrutiny from investors, and raises red flags about what happens when a founder ...

23andMe has a new health initiative—here’s what you should know about what information the brand will collect, and why they’ve been in the news lately.